Pacific Biosciences of California (PACB) reported preliminary Q1 revenue of $36.9 million, down from $38.8 million a year earlier.
Analysts polled by FactSet expect $33.3 million.
The company said it expects 2025 revenue of between $155 million and $170 million.
Analysts surveyed by FactSet expect $160.9 million.
The company also said it plans to reduce staff and other costs to bring annualized non-GAAP operating expenses $45 million to $50 million below prior guidance of $270 million to $280 million.
Pacific plans to hold its Q1 earnings call on May 8, the company said.
Shares of the company were up more than 14% in recent Wednesday trading.
Price: 1.38, Change: +0.18, Percent Change: +14.58
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。